CD33 and neoplasm: Data from one patient with lung adenocarcinomas indicated an increased number of myeloid-derived suppressor cells (MDSCs; CD206+/CD33+/HLA-DR-) and double negative (CD4-/CD8-) T cells infiltrating this tumor when compared to the corresponding numbers of these cells in the blood (Table 2).